Markets

A collection of 658 posts

Paid-members only

Ticker Lane Featured

$TWST: Twist Bioscience Is Up 566% and Now Trades Above Wall Street's Raised Target. It All Rides on November 13.

Twist Bioscience surged 16% to lead the market on an Eli Lilly TuneLab AI deal and a Leerink upgrade, capping a 566% year. At 27x sales and above the bulls' raised target, the November 13 breakeven report is the first hard test.

Paid-members only

Geopolitics Featured

Maduro Is Gone. Venezuela's Debt Isn't.

Eight months after U.S. forces flew Nicolás Maduro out of Caracas, his successor met Donald Trump at the UN — and the largest sovereign debt restructuring ever attempted moved from theory to negotiation. The anatomy of the pile, and what actually gets paid.

Members only

Infrastructure Featured

Water Is the Next Utility Shock. Wall Street Already Knows.

America's water systems need over $1.25 trillion in the next 20 years, and ratepayers are the only checkbook left. A $40 billion water-utility merger is pending — and the equipment makers just went on sale.

Macro Featured

760,000 People Just Lost Their Health Insurance. The Government Says They Never Asked for It.

CMS canceled 315,000 marketplace enrollments covering 760,000 people and froze new broker registrations weeks before open enrollment. The fraud is real. So is the coverage crisis it conveniently obscures.

Paid-members only

Energy Featured

The Winter Gas Trade Runs Through Louisiana

Qatar's LNG has been locked out of the market since June. Europe enters winter 15 points short on storage. The only swing supplier left is the US Gulf Coast — and the trade has several legs.

Paid-members only

Ticker Lane Featured

$ATYR: The FDA Just Cleared aTyr's Second Shot. The Market Values the Company at Less Than Its Bank Account.

aTyr Pharma got FDA alignment on a new Phase 3 for efzofitimod a year after an 83% one-day collapse. At $0.37, below net cash, the next sixty days decide the trade, not the science: a reverse-split vote and a Nasdaq deadline.

Paid-members only

Space Economy Featured

$VSAT: Viasat Spent a Decade Building the Wrong Network. The Stock Rose Tenfold Anyway.

Viasat just completed the satellite constellation it spent a decade building — years late, one satellite crippled, and aimed at a market Starlink already took. The stock is up tenfold anyway. Here's what the market is actually paying for.

Finance Featured

Set Up to Fail: The $694 Million Reckoning for America's Subprime Car Loans

More than 40 attorneys general just extracted $694 million from Credit Acceptance, alleging America's best-known subprime auto lender made car loans its own models predicted would fail. The stock barely flinched. Here's what the settlement actually changes.

Paid-members only

AI Featured

$INOD: The Company That May Be Training Meta's Muse Just Got Outed. The Stock Is Up 22% in Two Days.

Innodata rallied 22% in two sessions after Hunterbrook tied its biggest unnamed customer to Meta's hit AI agent Muse. The filings show a $67 million prepayment tell, a diversifying customer base, and a valuation hanging on one unconfirmed sentence.

Members only

Markets Featured

One of Wendy's Biggest Franchisees Just Went Bankrupt. It Won't Be the Last.

Meritage Hospitality ran 314 Wendy's across 15 states. It just filed Chapter 11 — with Wendy's own franchise arm as its biggest creditor. Dining traffic is falling, menu inflation is outrunning groceries, and the Fed just raised rates. The market has already picked the survivors.

Members only

Markets Featured

The World's Fastest-Growing Economy Can't Keep Foreign Money

India grew 7.8% last quarter — and foreign investors just sold a record $26 billion of its stocks. Inside the widening gap between the Indian economy and the Indian market, and the five signposts that would mark the turn.

Paid-members only

Markets Featured

$GRAL: The FDA Votes on Grail's Cancer Blood Test Tomorrow. The Stock Already Paid Itself a Third for the Paperwork.

Finance Featured

Commercial Real Estate Was Waiting for Rate Cuts. It Got a Hike.

An $875 billion wall of commercial mortgages comes due in 2026. The playbook was extend, pretend, and wait for cheaper money. The Fed just took the plan away.

Paid-members only

Defence Featured

Europe's Drone Wall Is Due in 100 Days. The Drones Aren't Waiting.

Brussels gave itself until New Year's to field a continental counter-drone network. NATO pledged $40 billion. The winners aren't the missile primes — they're the sensor, jamming, and cheap-effector layer.

Members only

Markets Featured

Boeing's Biggest Bottleneck Is Now Boeing

Boeing's CEO just admitted the 737 ramp is stuck on the company's own wing shop, not the supply chain. The real trade: 30-plus finished jets parked on the ramp, a multi-billion-dollar inventory unlock, and a margin flip dated to next year.

Paid-members only

Markets Featured

Top 10 Stocks We're Watching This Week — Summit Week Edition

Refineries burning on two continents while crude falls 9 percent, the Xi-Trump summit Thursday, Micron's positioning week, and the SEC's tokenization runway. Ten fresh names for the week ahead, all tracked on the Watchlist from these prices.

Paid-members only

Geopolitics Featured

The Oil Market Just Lost Its Plan B. It's Acting Like Nothing Happened.

Drones shut Saudi Arabia's Hormuz bypass just as tankers came under fire in the strait itself. Both exits from the Gulf are now contested — and $105 Brent is pricing the repair, not the precedent.

Paid-members only

Energy Featured

Copper's Record Lasted Five Days. The Shortage Didn't.

LME copper hit an all-time high of $14,875 a ton on September 10, then fell 6% in five days — on a Washington headline, not a single ton of new supply. The curve flipped to contango while the deficit forecasts never moved. Which signal do you trust with your money?

Paid-members only

Energy Featured

Is the Copper Squeeze Over? The Smelters Say No.

Copper fell 6% from its record and the futures curve flipped to contango — but the benchmark fee for smelting copper just reset to zero. What the concentrate market knows that the warehouse data doesn't.

Paid-members only

Finance Featured

The First Drug That Edits Your DNA Is Finally Selling

Casgevy revenue grew 78% in a single quarter and the FDA just opened the label to two-year-olds. The first CRISPR medicine is finally a business — and the market is still pricing its maker like a science project.

Paid-members only

Markets Featured

The Quantum Trade Isn't About Quantum Computers

On Monday, Washington retires the certification standard behind thousands of encryption products — the first hard deadline in a forced, decade-long rebuild of the internet's cryptographic plumbing. The money gets spent whether Q-Day ever arrives or not.

Macro Featured

The First Rate Hike of the War Economy

The Fed just raised rates for the first time since 2023 — days after the second-worst consumer sentiment reading on record. What a tightening cycle in a war economy means for inflation, mortgages, and markets.

Finance Featured

Sports Just Had a $30 Billion Summer. The Sellers Know Something.

The Lakers sold twice in 14 months, the Seahawks and Angels set league records, and $30 billion in franchises changed hands in one summer. Why America's founding sports families are all selling at once — and what it signals for the asset class.

Members only

Markets Featured

America's First Transcontinental Railroad Is on Trial

Union Pacific's $85 billion bid for Norfolk Southern just entered its merits phase at the STB — with every rival railroad, two unions, and half the shipping industry against it. The 16% merger spread says the market is pricing a coin flip.

Paid-members only

Finance Featured

Crypto's Big Bill Just Died 10 Votes Short. The Next Vote Is the Midterms.

The friendliest Congress crypto will ever get just killed its market-structure bill 50-49. Who regulates digital assets for the next 15 months, and why Circle and Coinbase are opposite trades.